한글목차

세계 고양이 백신 시장의 미래는 동물병원, 펫숍, 온라인 소매업체 채널의 기회로 인해 유망합니다. 세계 고양이 백신 시장은 2025-2031년 7.2%의 연평균 복합 성장률(CAGR)로 2031년까지 약 19억 달러에 달할 것으로 예상됩니다. 이 시장의 주요 촉진요인은 고양이 사육 수 증가와 고양이 매개 질병을 예방하기 위한 백신 접종에 대한 큰 수요입니다.

• Lucintel의 예측에 따르면 기술 부문에서는 고효율로 항체 면역 반응과 세포성 면역 반응을 모두 자극할 수 있는 약독성 생백신이 계속해서 가장 큰 부문이 될 것으로 예상됩니다.
• 판매 채널 카테고리에서는 동물병원이 예측 기간 중 가장 높은 성장세를 보일 것으로 예상됩니다.
• 지역별로 보면 심각한 질병으로부터 고양이를 보호하기 위한 백신 접종에 대한 정부의 엄격한 규제와 미국의 고양이 사육률 증가로 인해 북미가 여전히 가장 규모가 큰 지역이 될 것으로 보입니다.

고양이 백신 시장의 전략적 성장 기회

고양이 백신 시장의 성장은 기술 발전, 반려동물 사육 증가, 고양이 건강에 대한 인식 증가에 힘입어 주요 용도에 많은 전략적 기회를 제공합니다.

• 예방접종 증가: 예방접종 프로그램 증가는 성장 기회를 제공합니다. 백신의 이점에 대한 인식이 높아짐에 따라 고양이 질병에 대한 예방접종률을 높이고 발생 빈도를 낮추는 것이 요구되고 있습니다.
• 첨단 백신 제제 개발: 혼합 백신과 개인 맞춤형 백신을 포함한 차세대 백신은 완전히 새로운 시장 부문을 개발할 수 있습니다. 이러한 혁신은 특정 건강상의 필요를 충족시키고, 백신의 효능을 향상시키며, 시장 성장에 긍정적인 영향을 미칠 것입니다.
• 백신 전달 방법의 혁신 : 비강주사, 경구용 백신 등 백신 접종을 위한 새로운 전략이 개발되고 있습니다. 이를 통해 백신의 수용률과 투약률이 향상되고, 이 기술이 주류가 될 가능성이 높아질 것으로 예상됩니다.
• 신흥 시장 성장: 반려동물 사육이 증가하고 있는 신흥 시장으로의 진출은 확장의 여지가 큽니다. 이러한 지역에 적합한 솔루션을 맞춤화함으로써 이 시장 공간에서 더 큰 점유율을 확보할 수 있습니다.
• 고양이 건강 연구에 집중: 새로운 고양이 질병에 대한 백신 개발을 위한 연구에 대한 투자는 성장 잠재력을 가지고 있습니다. 새로운 건강 위협에 대응하고 기존 백신을 개선함으로써 시장 경쟁력과 혁신성을 높일 수 있습니다.

이러한 요인들로 인해 예방의학, 기술 발전, 시장 확대에 중점을 둔 고양이 백신 시장이 형성되고 있습니다.

고양이 백신 시장 활성화 요인 및 과제

고양이 백신 시장은 기술 발전, 경제 요인, 규제 변화 등 여러 가지 시장 성장 촉진요인 및 과제에 영향을 받습니다. 따라서 이러한 요인을 이해하는 것은 시장 상황을 파악하는 데 매우 중요합니다.

고양이 백신 시장을 촉진하는 요인은 다음과 같습니다. :

• 기술 발전: 새로운 제형과 전달 방법 등 백신 기술 혁신이 시장 성장의 원동력이 되고 있습니다. 이러한 발전은 백신의 효능과 투여의 용이성을 향상시켜 백신 채택 증가와 시장 확대를 지원하고 있습니다.
• 반려동물 보유율 증가: 전 세계 반려동물 보유율 증가로 고양이 백신에 대한 수요가 증가하고 있습니다. 반려동물을 키우고 반려동물의 건강을 우선시하는 사람들이 늘어남에 따라 효과적인 백신 접종 솔루션에 대한 필요성이 높아져 시장 잠재력을 높이고 있습니다.
• 예방 의료에 대한 관심: 예방접종을 포함한 반려동물의 예방 의료에 대한 관심이 높아지고 있습니다. 이러한 추세는 질병 예방에 있으며, 백신 접종의 중요성에 대한 인식이 높아짐에 따라 시장 성장에 기여하고 있습니다.

고양이 백신 시장이 해결해야 할 과제는 다음과 같습니다. :

• 규제적 과제: 규제적 과제: 백신의 안전성과 유효성에 대한 엄격한 규제 요건은 백신 제조업체에게 도전이 될 수 있습니다. 이러한 규제를 극복하고 규정을 준수하는 것은 제품 개발 일정과 시장 진입에 영향을 미칠 수 있습니다.
• 경제적 제약: 원자재 비용의 변동과 백신의 가격 등 경제적 요인은 시장 역학에 영향을 미칠 수 있습니다. 제조업체는 시장에서 경쟁력을 유지하기 위해 비용과 품질의 균형을 유지해야 합니다.

이러한 촉진요인 및 과제는 제품 개발, 시장 개발, 규제 준수에 영향을 미치며 고양이 백신 시장을 형성합니다.

목차

제1장 개요

제2장 세계의 고양이 백신 시장 : 시장 역학

• 서론, 배경, 분류
• 공급망
• 업계의 촉진요인과 과제

제3장 시장 동향과 예측 분석(2019-2031년)

• 거시경제 동향(2019-2024년)과 예측(2025-2031년)
• 세계의 고양이 백신 시장 동향(2019-2024년)과 예측(2025-2031년)
• 세계의 고양이 백신 시장 : 기술별
  • 약독생백신
  • 결합 백신
  • 불활화 백신
  • 서브유닛 백신
  • 톡소이드 백신
  • DNA 백신
  • 재조합 백신
• 세계의 고양이 백신 시장 : 연령별
  • 6개월 미만
  • 6개월 이상
• 세계의 고양이 백신 시장 : 유통 채널별
  • 수의 클리닉
  • 애완동물 숍
  • 온라인 소매업체

제4장 지역별 시장 동향과 예측 분석(2019-2031년)

• 세계의 고양이 백신 시장 : 지역별
• 북미의 고양이 백신 시장
• 유럽의 고양이 백신 시장
• 아시아태평양의 고양이 백신 시장
• 기타 지역의 고양이 백신 시장

제5장 경쟁 분석

• 제품 포트폴리오 분석
• 운영 통합
• Porter's Five Forces 분석

제6장 성장 기회와 전략 분석

• 성장 기회 분석
  • 세계의 고양이 백신 시장의 성장 기회 : 기술별
  • 세계의 고양이 백신 시장의 성장 기회 : 연령별
  • 세계의 고양이 백신 시장의 성장 기회 : 유통 채널별
  • 세계의 고양이 백신 시장의 성장 기회 : 지역별
• 세계의 고양이 백신 시장의 새로운 동향
• 전략적 분석
  • 신제품 개발
  • 세계의 고양이 백신 시장의 생산능력 확대
  • 세계의 고양이 백신 시장에서의 기업인수합병(M&A), 합병사업
  • 인증과 라이선싱

제7장 주요 기업의 개요

• Elanco Animal Health
• Boehringer Ingelheim
• Merck
• Zoetis
• Bioveta Lubricant Additives Company

영문목차

The future of the global cat vaccine market looks promising with opportunities in the veterinary clinic, pet store, and online retailer channels. The global cat vaccine market is expected to reach an estimated $1.9 billion by 2031 with a CAGR of 7.2% from 2025 to 2031. The major drivers for this market are the rising cat ownership and the significant demand for vaccinations to prevent cat-transmitted diseases.

• Lucintel forecasts that, within the technology category, attenuated live will remain the largest segment due to their high efficiency and ability to stimulate both antibody and cellular immune responses.
• Within the distribution channel category, veterinary clinics are expected to witness the highest growth over the forecast period.
• In terms of regions, North America will remain the largest region due to strict government regulations regarding vaccination in protecting cats from serious diseases and the rising adoption of cats in the USA.

Gain valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Cat Vaccine Market

The cat vaccine market is witnessing several emerging trends that reflect advancements in technology, shifts in consumer preferences, and evolving regulatory requirements.

• Increased Focus on Combination Vaccines: There has been a shift toward combination vaccines that protect against multiple diseases at once. Pet owners benefit from this since it is more convenient for them and reduces the number of veterinary visits, thereby enhancing overall vaccination compliance.
• Advancements in Vaccine Delivery Methods: Nasal inhalation and oral vaccines are being increasingly used. These innovations aim to reduce the stress associated with the vaccination of cats and make the process easier. As such, preventive healthcare may be boosted.
• Development of Personalized Vaccines: The market is seeing the development of personalized vaccines tailored to the specific health needs of individual cats. This trend aims to enhance vaccine efficacy and reduce the risk of adverse reactions, improving overall health outcomes.
• Growth of Preventive Healthcare: There is a growing emphasis on preventive healthcare for pets, including vaccinations. This trend reflects a shift toward proactive health management and increased awareness of the importance of vaccination in preventing diseases.
• Expansion into Emerging Markets: The cat vaccine market is expanding into emerging markets where pet ownership is increasing. Companies are focusing on providing affordable and effective vaccines to meet the growing demand in these regions.

These trends are reshaping the cat vaccine market by enhancing vaccine technology, improving accessibility, and promoting preventive care.

Recent Developments in the Cat Vaccine Market

Several critical developments demonstrate the growth of the cat vaccine industry in terms of technology, focus on feline health, and expanding market opportunities.

• Introduction of Combination Vaccines: New combination vaccines are being introduced that protect against several feline diseases with a single dose. This development helps increase the efficiency of vaccinations and makes it easier for pet owners and veterinarians to vaccinate pets.
• Advancement in Vaccine Delivery Systems: The simplicity of administering vaccines has been enhanced by advances in vaccine delivery systems, such as intranasal and oral vaccines. These innovations aim to reduce cats' stress levels and increase compliance with vaccination programs.
• Expansion of Vaccine Research: Increasing research endeavors are targeting emerging feline diseases and improving current vaccine formulations. This expansion addresses new health challenges while making vaccination more effective and safer.
• Growth in Market Accessibility: Efforts are underway to ensure increased accessibility of vaccines in regions with no access, driven by rising pet ownership rates and increased awareness of feline health. This development includes the introduction of affordable vaccines and expansion into rural areas.
• Personalized Vaccine Development: Personalized vaccines that match the medical requirements of individual cats are being created. This personalized approach ensures that vaccines work better, minimizing adverse reactions and providing better-targeted and safe vaccination options.

These advancements boost vaccine technology, expand research initiatives, enhance accessibility, and improve market reach toward developing cat vaccine products.

Strategic Growth Opportunities for Cat Vaccine Market

Market growth in cat vaccines offers many strategic opportunities for key applications, propelled by advancements in technology, increasing pet ownership, and awareness of feline health.

• Increasing Preventive Vaccination: Increasing preventive vaccination programs present growing opportunities. The rising awareness of the benefits of vaccines calls for increased coverage levels and reduced frequency of occurrence for cat diseases.
• Development of Advanced Vaccine Formulations: The new generation of vaccines, including combined and personalized vaccines, could open up a completely new market segment. These breakthroughs address specific health needs and improve vaccine efficacy, positively impacting market growth.
• Innovation in Vaccine Delivery Methods: New strategies, such as nasal sprays or oral vaccines, are being developed for vaccination. This is expected to result in better acceptance and administration rates, thereby raising the chances for this technology to become mainstream.
• Emerging Market Growth: Expanding into emerging markets where pet ownership is increasing provides considerable scope for expansion. Customizing solutions that fit these areas can help capture a larger share of this market space.
• Focus on Feline Health Research: Investment in research aimed at developing vaccines for emerging feline diseases holds growth potential. Addressing new health threats and improving existing vaccines can enhance market competitiveness and innovation.

These factors are shaping the cat vaccine market with an emphasis on preventive care, technological advancements, and expanding markets.

Cat Vaccine Market Driver and Challenges

The cat vaccine market is influenced by several drivers and challenges, such as technological advancements, economic factors, and regulatory changes. Therefore, understanding these elements is crucial for navigating the market landscape.

The factors driving the cat vaccine market include:

• Technological Advancements: Innovations in vaccine technology, including new formulations and delivery methods, are driving market growth. These advancements enhance vaccine efficacy and ease of administration, supporting increased adoption and market expansion.
• Rising Pet Ownership: Increasing pet ownership globally is driving demand for cat vaccines. As more people acquire pets and prioritize their health, the need for effective vaccination solutions is growing, boosting market potential.
• Focus on Preventive Healthcare: There is a growing emphasis on preventive healthcare for pets, including vaccination. This trend reflects increased awareness of the importance of vaccination in preventing diseases, contributing to market growth.

Challenges in the cat vaccine market include:

• Regulatory Challenges: Stringent regulatory requirements for vaccine safety and efficacy pose challenges for manufacturers. Navigating these regulations and ensuring compliance can impact product development timelines and market entry.
• Economic Constraints: Economic factors, such as fluctuations in raw material costs and the affordability of vaccines, can impact market dynamics. Manufacturers need to balance cost and quality to maintain competitiveness in the market.

These drivers and challenges shape the cat vaccine market by influencing product development, market growth, and regulatory compliance.

List of Cat Vaccine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies cat vaccine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the cat vaccine companies profiled in this report include-

• Elanco Animal Health
• Boehringer Ingelheim
• Merck
• Zoetis
• Bioveta

Cat Vaccine by Segment

The study includes a forecast for the global cat vaccine market by technology, age, distribution channel, and region.

Cat Vaccine Market by Technology [Analysis by Value from 2019 to 2031]:

• Attenuated Live Vaccines
• Conjugate Vaccines
• Inactivated Vaccines
• Subunit Vaccines
• Toxoid Vaccines
• DNA Vaccines
• Recombinant Vaccines

Cat Vaccine Market by Age [Analysis by Value from 2019 to 2031]:

• Below 6 Months
• Above 6 Months

Cat Vaccine Market by Distribution Channel [Analysis by Value from 2019 to 2031]:

• Veterinary Clinics
• Pet Stores
• Online Retailers

Cat Vaccine Market by Region [Analysis by Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Cat Vaccine Market

Advancements in veterinary medicine, changing pet ownership trends, and increased awareness of animal health have led to the rapid evolution of the cat vaccine market. Recent advancements in this field indicate improvements in vaccine technology and feline health and safety efforts across various regions.

• United States: In the US, there has been significant progress with the introduction of new combination vaccines that can address multiple feline diseases in one shot. Improvements in vaccine formulations aim to enhance efficacy and reduce side effects. The market is also experiencing a transition toward longer-lasting immunity vaccines.
• China: China's focus is now on creating vaccines that combat emerging feline infections and improving existing immunization programs. There has been an upsurge in research activities within this market, supported by government initiatives for animal health and safety.
• Germany: Germany's market is progressing due to novel ways of delivering vaccines, such as intranasal or oral options for cats. These innovations aim to improve vaccination compliance and ease of administration. In addition, Germany seeks vaccines with broader protection against viral and bacterial infections.
• India: India requires cost-effective and efficient cat vaccines due to the rise in pet ownership and increased awareness of cat health issues across the country. Other developments include affordable vaccines whose coverage has been broadened into rural areas.
• Japan: In Japan, the market for cat vaccines has seen a revolution through personalized vaccinations tailored to the health status of individual cats. This involves creating effective vaccines that minimize harmful reactions, improving performance. Additionally, Japan is exploring new technologies for the production and distribution of vaccine products.

Features of the Global Cat Vaccine Market

Market Size Estimates: Cat vaccine market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.

Segmentation Analysis: Cat vaccine market size by technology, age, distribution channel, and region in terms of value ($B).

Regional Analysis: Cat vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different technologies, ages, distribution channels, and regions for the cat vaccine market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the cat vaccine market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the cat vaccine market by technology (attenuated live vaccines, conjugate vaccines, inactivated vaccines, subunit vaccines, toxoid vaccines, DNA vaccines, and recombinant vaccines), age (below 6 months and above 6 months), distribution channel (veterinary clinics, pet stores, and online retailers), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Cat Vaccine Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

• 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
• 3.2. Global Cat Vaccine Market Trends (2019-2024) and Forecast (2025-2031)
• 3.3: Global Cat Vaccine Market by Technology
  • 3.3.1: Attenuated Live Vaccines
  • 3.3.2: Conjugate Vaccines
  • 3.3.3: Inactivated Vaccines
  • 3.3.4: Subunit Vaccines
  • 3.3.5: Toxoid Vaccines
  • 3.3.6: DNA Vaccines
  • 3.3.7: Recombinant Vaccines
• 3.4: Global Cat Vaccine Market by Age
  • 3.4.1: Below 6 Months
  • 3.4.2: Above 6 Months
• 3.5: Global Cat Vaccine Market by Distribution Channel
  • 3.5.1: Veterinary Clinics
  • 3.5.2: Pet Stores
  • 3.5.3: Online Retailers

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

• 4.1: Global Cat Vaccine Market by Region
• 4.2: North American Cat Vaccine Market
  • 4.2.1: North American Market by Technology: Attenuated Live Vaccines, Conjugate Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, DNA Vaccines, and Recombinant Vaccines
  • 4.2.2: North American Market by Distribution Channel: Veterinary Clinics, Pet Stores, and Online Retailers
• 4.3: European Cat Vaccine Market
  • 4.3.1: European Market by Technology: Attenuated Live Vaccines, Conjugate Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, DNA Vaccines, and Recombinant Vaccines
  • 4.3.2: European Market by Distribution Channel: Veterinary Clinics, Pet Stores, and Online Retailers
• 4.4: APAC Cat Vaccine Market
  • 4.4.1: APAC Market by Technology: Attenuated Live Vaccines, Conjugate Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, DNA Vaccines, and Recombinant Vaccines
  • 4.4.2: APAC Market by Distribution Channel: Veterinary Clinics, Pet Stores, and Online Retailers
• 4.5: ROW Cat Vaccine Market
  • 4.5.1: ROW Market by Technology: Attenuated Live Vaccines, Conjugate Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, DNA Vaccines, and Recombinant Vaccines
  • 4.5.2: ROW Market by Distribution Channel: Veterinary Clinics, Pet Stores, and Online Retailers

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Cat Vaccine Market by Technology
  • 6.1.2: Growth Opportunities for the Global Cat Vaccine Market by Age
  • 6.1.3: Growth Opportunities for the Global Cat Vaccine Market by Distribution Channel
  • 6.1.4: Growth Opportunities for the Global Cat Vaccine Market by Region
• 6.2: Emerging Trends in the Global Cat Vaccine Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Cat Vaccine Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Cat Vaccine Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Elanco Animal Health
• 7.2: Boehringer Ingelheim
• 7.3: Merck
• 7.4: Zoetis
• 7.5: Bioveta Lubricant Additives Company